VISIONARY SEMINAR, INTERNATIONAL MATCHMAKING AND CRASH COURSE FOR ENTREPRENEURS
Set of 3 events on 7., 8. and 14.Oct 2020.
Visionary Seminar ‘Digitalisation in Life Sciences: Growing the Future’
Wednesday 7.Oct 2020, 14:00-16:30 CET
The visionary seminar will have a focus on the potential and possibilities within the subject ‘Digitalisation in Life Sciences’: initiating digital transformation and change management in the health sector and trying to foresee the next 5-10 years of development. Estonia is one of the world’s most digitally enabled nations worldwide. Its IT R&D ecosystem enjoys global proof of concept, being trusted by many global organisations and companies.
Patient records in Estonia are digitized and secured, providing a single immutable data source for healthcare professionals. With a unique digital platform and collaborative ecosystem, Estonia is positioned to lead on preventative medicine, patient self-treatment, and industry efficiency. The solution called X-Road explained during the visionary seminar, allows Estonian medical records and drug prescriptions to be fully digitalised. X-Road provides numerous collaboration opportunities combining from one side ICT and medical technology companies with health care providers and public sector stakeholders from the other side. The Estonian Biobank was one of the first genome banks in the world with the aim to provide genetic data and allow us to visualise the relationship between genetic data and other health records. The developments of Estonian Biobank are presented by Tõnu Esko.
On the first part of visionary seminar Ain Aaviksoo gives a great insight in Estonia’s and GuardTime‘s efforts in the digitalisation in the life science sector, discussing the business opportunities with its leading digital and health companies and research institutes and Estonia’s vision on the life science sector’s digitalisation in the near future.
During the second part of visionary seminar the future vision is taken to the next level:
Bart de Witte introduces the idea and challenges on building free medical artificial intelligence.
Liesbet Geris presents the state of the art of in silico medicine and discuss the challenges that need to be addressed for it (and for digitalisation in life sciences) to reach its full potential.
Sachin Gaur takes a look to the digital health innovation trends in world.
Both sessions are followed up by short Q&A, where you can directly communicate with the top leaders of the fields.
Find the programme here.
International matchmaking ‘Digitalisation in Life Sciences’
Digital event, B2Meets platform
Thursday, 8. Oct 2020, 14 CET – 15. Oct 2020 14 CET
A week-long matchmaking on B2Meets platform for life science enterprises. The digital matchmaking event starts with two short presentations for SMEs. One from the EIT Health Bridgehead programme on the financing possibilities for SMEs and an introduction to a cooperation experience story from a foreign entrepreneur about their cooperation with Estonian companies. Followed by pitches of participating life science and digitalisation companies looking for cooperation.
Companies taking part in the matchmaking can enter their description and keywords – for automated search – on the matchmaking platform and have a 2’ pitch to present themselves.
Find the programme here.
Crash course on Internationalisation
Wednesday, 14. Oct 2020, 14 CET
The path to foreign markets is not always clear. There are many aspects to be considered – f.e. cultural, legal and economic – and taking the first step may seem difficult. In addition, after making the first contact, staying and being present in the new market requires a strong commitment.
To make this process more clear we will discuss different strategies on entering foreign markets and talk about potential target markets in digitalisation of healthcare. Concerning the latter, the crash course will, amongst others, discuss the digitalisation in healthcare in Estonia, India and Australia.
All participating SMEs are more than welcome to share their experiences.
The workshop will be followed up by online advice and facilitation by the partnership clusters BioRN Life Science Cluster Rhine-Neckar (Germany), Smart Hub Flemish Brabant (Belgium), BioPeople (Denmark) and Tartu Health Cluster (Estonia).
Find the programme here.
The set of three events is without a participation fee.
For additional information please contact: Eleri Seer, Tartu Biotechnology Park, or +372 55555109
CELIS – Cluster Excellence in Life sciences – Internationalisation of SMEs. CELIS is one of the 12 cluster excellence strategic partnerships – ESCP-4x. Links: https://www.health-axis.eu/celis / https://www.clustercollaboration.eu/escp-4x-profiles/celis
Speakers of the visionary seminar
Ain Aaviksoo, MD MPH is the Chief Medical Officer of Guardtime Health.
Prior to this he worked as Undersecretary for E-services and Innovation for the Estonian government overseeing the digital transformation and innovation of healthcare, labour and social matters.
Dr Aaviksoo obtained MD from University of Tartu and MPH from Harvard University.
He has earlier work experience as a physician, senior level civil servant, international level consultant on large system transformation and technology adoption in healthcare, health policy researcher, CEO of public policy think-tank Praxis and as a health-tech entrepreneur.
Dr Aaviksoo has published over 20 peer-reviewed articles and contributed to several book chapters on health policy and e-health, he also regularly presents as invited keynote speaker on digital services and healthcare.
Tõnu Esko, PhD, is a Vice Director of Development and head of Estonian Biobank Innovation Center at Institute of Genomics, University of Tartu, where he holds Professor Human Genomics position genomics. Dr Esko is also a Research Scientist at the Broad Institute of Harvard and MIT, Cambridge, USA and visiting researcher at the Children’s Hospital Boston and Harvard Medical School, Boston, USA. He has founded and is co-leading several international consortia. He serves as Scientific Advisory Board member for several global companies.
The Estonian Biobank hosts a comprehensive data repository of 200,000 participants from Estonia. Over the past 13 years, Dr Esko has been coordinating Biobank R&D activities both in native Estonia and internationally, both in the academic and private sector. He has also been a crucial member of the Biobank’s strategic leadership team in areas of fundraising, investment decision making on IT, technology and data infrastructure, and building partnerships with leading academic and industry players. His team is contributing to the Estonian Precision Medicine Initiative related activities by developing computational algorithms and feedback reports for personalized medicine applications.
Currently his work at Estonian Biobank Innovation Center is focused on building public private partnerships both with early-stage startups, SMEs, global corporations and VC funds across the fields of HealthTech, BioTech and MedTech by utilizing the rich Estonian Biobank digital health repositories as well as world-class scientific expertise. His latest endeavor is to set up a holding company for University of Tartu, an entity to park IP and data access based equity from startups, accelerators and even VC fonds.
Bart de Witte, is one of Europe’s leading and awarded experts on the digital transformation of healthcare, and one of the most progressive forward thinkers focuses on finding alternative European strategies for the current postmodern world to create a more desirable future with greater social benefits. He is the initiator of the HIPPO AI Foundation in Berlin, which aims to establish the first global NGO for open source-based artificial intelligence in medicine. He is involved as a mentor for dozen digital health start-ups and lectures at various universities in Germany, Belgium, Switzerland, Austria and China. He co-founded the Digital Health Academy where he shares his knowledge to improve digital literacy.
Liesbet Geris is Collen-Francqui Research Professor in Biomechanics and Computational Tissue Engineering at the University of Liège and KU Leuven in Belgium. Her research focusses on the multi-scale and multi-physics modelling of biological processes. Together with her team and their clinical and industrial collaborators, she uses these models to investigate the etiology of non-healing fractures, to design in silico potential cell-based treatment strategies and to optimize manufacturing processes of these tissue engineering constructs. Liesbet is scientific coordinator of the Prometheus platform for Skeletal Tissue Engineering (50+ researchers). She has edited several books on computational modelling and tissue engineering. She has received 2 prestigious ERC grants (starting in 2011 and consolidator in 2017) to finance her research and has received a number of young investigator and research awards from the in silico and regenerative medicine communities. She is a former member and chair of the Young Academy of Belgium (Flanders) and member of the strategic alliance committee of the Tissue Engineering and Regenerative Medicine Society. She is the current executive director of the Virtual Physiological Human Institute and in that capacity she advocates the use of in silico modeling in healthcare through liaising with the clinical community, the European Commission and Parliament, regulatory agencies (EMA, FDA) and various other stakeholders. Besides her research work, she is often invited to give public lectures on the challenges of interdisciplinary in research, women in academia and digital healthcare.
Sachin Gaur, Director Operations, InnovatioCuris, is a researcher cum entrepreneur in space of mobile and Internet solutions. He was in top 10 innovators in India under India Innovates Growth Programme 2013 by FICCI. He is involved in multiple ventures in the domain of digital marketing, mobile solutions and the Internet of Things.
He has a double M.Sc.(tech) in Mobile Security and Cryptography from Aalto University, Finland and University of Tartu, Estonia. He has worked in past with organizations like Adobe, C.E.R.N. and in research at the Aalto University in security-related topics.
Also, he has a dozen patents issued/pending in USPTO apart from contributing book chapters in two books on topics of Innovation and Healthcare.
CELIS is funded by the European Union’s COSME Programme (GA No.: 873857).
The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Executive Agency for Small and Medium-sized Enterprises (EASME) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.